🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to observe and evaluate the efficacy and safet...
Status
Unknown
Location
The First Affiliated Hospital of Zhengzhou University
Start Date
2021-09
Trial ID
NCT03766178
Treatments Being Tested
The prognosis of patients with inoperable locally advanced or residual/rela...
Status
Unknown
Location
Radiotherapy Department of Cancer Hospital, Chinese Academy of Medical Sciences
Start Date
2010-05
Trial ID
NCT01180166
Treatments Being Tested
To evaluate the efficacy and safety of nimotuzumab in the treatment of EGFR...
Status
Unknown
Location
Tianjin Medical University Second Hospital
Start Date
2022-12-01
Trial ID
NCT06022276
Treatments Being Tested
This is an multicenter, randomized，double-blind, controlled clinical study....
Status
Completed
Location
Cancer Institute and Hospital , Chinese Academy of Medical Sciences
Start Date
2017-07-06
Trial ID
NCT06781073
Treatments Being Tested
Over-expression of Epidermal Growth Factor Receptor (EGFR) on cells occurs ...
Status
Recruiting
Location
Royal University Hospital
Start Date
2020-02-01
Trial ID
NCT04235114
Treatments Being Tested
To investigate the efficacy and safety of nimotuzumab combined with concurr...
Status
Unknown
Location
Peking University 3rd Hospital
Start Date
2020-12
Trial ID
NCT04678791
Treatments Being Tested
In order to evaluate the efficacy and safety of nimotuzumab combined with p...
Status
Recruiting
Location
National Sun Yat-sen University Cancer Center
Start Date
2024-08-01
Trial ID
NCT05978050
Treatments Being Tested
The purpose of this phase II trial is to determine the feasibility and effi...
Status
Unknown
Location
Zhujiang Hospital
Start Date
2018-03-20
Trial ID
NCT03469531
Treatments Being Tested
This study is a prospective, single-arm, multicenter study. The patients we...
Status
Recruiting
Location
Feng Wang
Start Date
2023-03-08
Trial ID
NCT06718205
Treatments Being Tested
The purpose of this study is studying induction nimotuzumab plus gemcitabin...
Status
Withdrawn
Location
Sun Yat-sen University Cancer Center
Start Date
2015-04-01
Trial ID
NCT02428764
Treatments Being Tested